ST. PAUL, Minn. — A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing ...

A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing cancer in the ...

Johnson & Johnson is rated a buy, with accelerating revenue and earnings growth driven by TREMFYA, CARVYKTI, and robust MedTech innovation. JNJ's portfolio reshaping (divesting Orthopaedics and ...

A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer. The jury awarded $18 million to Monica Kent and $22 ...

LSU senior guard Flau’jae Johnson is a true creative in every sense of the word — even down to the way she makes cereal. On Monday morning, Johnson gave a behind-the-scenes look at how she makes the ...

House Speaker Mike Johnson (R-La.) opened up in a revealing Wednesday interview alongside his wife Kelly, sharing some of the challenges he has faced since taking the reins of the lower chamber amid ...

A meeting between Prime Minister of the Republic of Armenia Nikol Pashinyan and President of France Emmanuel Macron took place at the Élysée Palace. The interlocutors discussed a number of issues on ...

House Speaker Mike Johnson (R-La.) will hold his daily press conference Wednesday morning as pressure mounts on both sides of the aisle to reopen the government after funding lapsed nearly a month ago ...

Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes—the latest attempt to slim down by the healthcare giant.

Oct 10 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab is in discussions to buy Protagonist Therapeutics (PTGX.O), opens new tab, a source familiar with the matter told Reuters. Shares of ...

A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial alleging its talc products cause ...